Induction of Cross-Linking and Silencing of Sp1 by Transglutaminase during Liver Injury in ASH and NASH via Different ER Stress Pathways

By  

Digestive Diseases, Vol. 28, Iss. 6, 2011-04 ,pp. : 715-721

Karger

Access to resources Recommend Favorite

Hepatocellular carcinoma and NASH

By Kudo Masatoshi  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 409-411

Springer Publishing Company

Access to resources Recommend Favorite

NAFLD-NASH: An Under-Recognized Epidemic

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 209-213

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical usefulness of AGEs as a biomarker for the attenuation of NASH

By Tasci Ilker  

Journal of Gastroenterology, Vol. 45, Iss. 7, 2010-07 ,pp. : 779-780

Springer Publishing Company

Access to resources Recommend Favorite

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

By Yoneda Masato   Mawatari Hironori   Fujita Koji   Iida Hiroshi   Yonemitsu Kyoko   Kato Shingo   Takahashi Hirokazu   Kirikoshi Hiroyuki   Inamori Masahiko   Nozaki Yuichi   Abe Yasunobu   Kubota Kensuke   Saito Satoru   Iwasaki Tomoyuki   Terauchi Yasuo   Togo Shinji   Maeyama Shiro   Nakajima Atsushi  

Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-07 ,pp. : 573-582

Springer Publishing Company

Access to resources Recommend Favorite